A dose-finding and discontinuation study of clomipramine in panic disorder

Journal of Psychopharmacology

Volumn 15, Issue 1, 2001, Pages 13-17

  Lotufo Neto, Francisco ^a,b   Bernik, Márcio ^b   Ramos, Renato T ^b   Andrade, Laura ^a   Gorenstein, Clarice ^a   Cordás, Taki ^a   Melo, Márcio ^a   Gentil, Valentim ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Santa Casa de Misericórdia de São Paulo   (Brazil)

Author keywords

Clomipramine; Discontinuation; Maintenance treatment; Panic disorder; Recurrence; Relapse; Remission

Indexed keywords

CLOMIPRAMINE;

ADOLESCENT; ADULT; AGORAPHOBIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLOMIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SINGLE-BLIND METHOD;

EID: 0035083450     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110101500103     Document Type: Article

References (53)

1. Outcome of panic disorder with or without concomitant depression: A 2-year prospective follow-up study
2. Medication discontinuation in panic disorder
3. Panic disorder: Efficacy of current treatments
4. Medication discontinuation in panic disorder
5. Follow-up on the treatment of panic disorder with or without agoraphobia: A quantitative review
6. An inventory for measuring depression
7. Predictors of short-term treatment response in 66 patients with panic disorder
8. Long-term drug treatment of panic disorder
9. Characteristics of placebo response during long-term treatment of panic disorder
10. Antidepressant and antimanic medications
11. The Galway study of panic disorder, I: Clomipramine and lofepramine in DSM III-R panic disorder: A placebo controlled trial
12. Increased antipanic efficacy in combined treatment with clomipramine and dixyrazine
13. Discontinuation of alprazolam treatment in panic patients
14. Fisiopatologia da sindrome do pânico
15. Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine
16. Treatment of spontaneous panic attacks with chlomipramine
17. Panic attacks and agoraphobia: Low dose clomipramine treatment
18. Chronic anxiety: Deciding the length of treatment
19. A rating scale for depression
20. Clomipramine treatment of agoraphobic women. An eight-week controlled trial
21. Long-term follow-up after a drug trial for panic disorder
22. The long-term course of panic disorder and its predictors
23. Course and outcome in panic disorder
24. Remission and relapse in subjects with panic disorder and panic with agoraphobia. A prospective short-interval naturalistic follow-up
25. The delineation of two drug-responsive anxiety syndromes
26. Lessons to be learned from long-term treatment of affective disorders: Potential utility in panic disorder
27. The comparative pharmacology of new antidepressants
28. Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia
29. Brief standard self-rating for phobic patients
30. Imipramine and brief therapist-aided exposure in agoraphobics having self exposure homework: A controlled trial
31. Two-year follow-up of exposure and imipramine treatment of agoraphobia
32. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia
33. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia
34. Superiority of clomipramine over imipramine in the treatment of panic disorder: A placebo controlled trial
35. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9 Year naturalistic follow-up study
36. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: Results of a naturalistic follow-up study
37. Maintenance treatment with antidepressants in panic disorder
38. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial
39. Long-term management of panic disorder
40. Long-term course and outcome of panic disorder
41. Clomipramine and initial worsening in panic disorder: Beyond the 'jitteriness syndrome'
42. Panic disorder: Long-term pharmacotherapy and discontinuation
43. Maintenance drug treatment of panic disorder. II. Short- and long-term outcome after drug taper
44. Treatment of panic disorder: The state of the art
45. Course and outcome in panic disorder: A review of recent follow-up studies
46. Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms
47. Gradual withdrawal of diazepam after long-term therapy
48. Natural course and spontaneous remissions of untreated anxiety disorders: Results of the Munich follow-up studies
49. Treatment of agoraphobia with group exposure in vivo and imipramine